Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration

RNA-guided genome surgery using CRISPR-Cas9 nucleases has shown promise for the treatment of diverse genetic diseases. Yet, the potential of such nucleases for therapeutic applications in nongenetic diseases is largely unexplored. Here, we focus on age-related macular degeneration (AMD), a leading c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyoungmi, Park, Sung Wook, Kim, Jin Hyoung, Lee, Seung Hwan, Kim, Daesik, Koo, Taeyoung, Kim, Kwang-eun, Kim, Jeong Hun, Kim, Jin-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340969/
https://www.ncbi.nlm.nih.gov/pubmed/28209587
http://dx.doi.org/10.1101/gr.219089.116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340969/
https://www.ncbi.nlm.nih.gov/pubmed/28209587
http://dx.doi.org/10.1101/gr.219089.116

Ejemplares similares